Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Hemophagocytic Lymphohistiocytosis in Adults (aHLH): Results from the German HLH Registry

Sebastian Birndt, Thomas Schenk, MD, Frank M. Brunkhorst, MD, Georg Maschmeyer, MD, Frank Rothmann, MD, Thomas Weber, MD, Markus Müller, MD, Jens P. Panse, MD, Roland Schroers, MD, Jan Braess, MD, Norbert Frickhofen, MD, Gritta Janka, MD PhD, Kai Lehmberg, MD, Andreas Hochhaus, MD, Thomas Ernst, MD, Paul La Rosée, MD

Blood (2016) 128 (22): 2523.

https://doi.org/10.1182/blood.V128.22.2523.2523

Published: 2016

Journal Articles

Bone Marrow Iron Assessment By MRI-R2* and Its Relation to Deferasirox Treatment in Patients with Iron Overload

Regine Grosse, MD, Suzan Acar, Bjoern Schoennagel, MD, Roland Fischer, PhD, Jin Yamamura, MD, Gritta Janka, MD PhD, Peter Nielsen, MD

Blood (2015) 126 (23): 3358.

https://doi.org/10.1182/blood.V126.23.3358.3358

Published: 2015

Journal Articles

Adult Patients with Hemophagocytic Lymphohistiocytosis (HLH) in Germany: A Retrospective Multicenter Case Study of 29 Patients

Thomas Schenk, MD, Georg Maschmeyer, MD, Frank Rothmann, MD, Thomas Weber, MD, Maximilian Christopeit, MD, Olaf Penack, MD, PhD, Daniela Goy, MD, Jens Panse, MD, Gritta Janka, MD, PhD, Andreas Hochhaus, MD, Paul La Rosee, MD

Blood (2012) 120 (21): 3271.

https://doi.org/10.1182/blood.V120.21.3271.3271

Published: 2012

Journal Articles

Optimizing Iron Chelator Treatment in Cardiac and Hepatic Siderosis: Efficacy of Divided Deferasirox (EXJADE R ) – Doses

Regine Grosse, MD, Andrea Jarisch, PhD, MD, Jin Yamamura, MD, Peter Nielsen, MD, Roland Fischer, PhD, Gritta Janka, MD, PhD

Blood (2011) 118 (21): 2110.

https://doi.org/10.1182/blood.V118.21.2110.2110

Published: 2011

Journal Articles

Safe and Efficient Chelation by Deferasirox In Thalassemia Major Patients with Low Liver and Cardiac Iron Concentrations

Regine Grosse, Gritta Janka, MD, PhD, Andrea Jarisch, PhD, MD, Peter Nielsen, Jin Yamamura, Roland Fischer, PhD

Blood (2010) 116 (21): 5168.

https://doi.org/10.1182/blood.V116.21.5168.5168

Published: 2010

Journal Articles

Comparison of the Predictive Value of MRD and PVA Score in Pediatric ALL.

Anja Troeger, MD, Gabriele Escherich, MD, Udo zur Stadt, PhD, M. L Den Boer, MSc, PhD, Rob Pieters, MD, PhD, Martin Zimmermann, PhD, Ulrich Göbel, MD, PhD, Arndt Borkhardt, MD, PhD, Dagmar Dilloo, MD, PhD, Gritta Janka, MD, PhD

Blood (2008) 112 (11): 1520.

https://doi.org/10.1182/blood.V112.11.1520.1520

Published: 2008

Journal Articles

High Expression of CD40 on BCP-ALL Blasts Is an Independent Risk Factor Associated with Improved Survival and Enhanced Capacity To Upregulate the Death Receptor CD95.

Anja Troeger, MD, Ludmila Glouchkova, PhD, Birgit Ackermann, PhD, Gabriele Escherich, MD, Roland Meisel, MD, Helmut Hanenberg, MD, Gritta Janka, MD, Ulrich Goebel, MD, Hans-Juergen Laws, MD, Dagmar Dilloo, MD

Blood (2006) 108 (11): 2282.

https://doi.org/10.1182/blood.V108.11.2282.2282

Published: 2006

NARROW

Hemophagocytic Lymphohistiocytosis in Adults (aHLH): Results from the German HLH Registry

Bone Marrow Iron Assessment By MRI-R2* and Its Relation to Deferasirox Treatment in Patients with Iron Overload

Adult Patients with Hemophagocytic Lymphohistiocytosis (HLH) in Germany: A Retrospective Multicenter Case Study of 29 Patients

Optimizing Iron Chelator Treatment in Cardiac and Hepatic Siderosis: Efficacy of Divided Deferasirox (EXJADE R ) – Doses

Safe and Efficient Chelation by Deferasirox In Thalassemia Major Patients with Low Liver and Cardiac Iron Concentrations

Comparison of the Predictive Value of MRD and PVA Score in Pediatric ALL.

High Expression of CD40 on BCP-ALL Blasts Is an Independent Risk Factor Associated with Improved Survival and Enhanced Capacity To Upregulate the Death Receptor CD95.

Email alerts

ASH Publications

American Society of Hematology

Hemophagocytic Lymphohistiocytosis in Adults (aHLH): Results from the German HLH Registry

Bone Marrow Iron Assessment By MRI-R2* and Its Relation to Deferasirox Treatment in Patients with Iron Overload

Adult Patients with Hemophagocytic Lymphohistiocytosis (HLH) in Germany: A Retrospective Multicenter Case Study of 29 Patients

Optimizing Iron Chelator Treatment in Cardiac and Hepatic Siderosis: Efficacy of Divided Deferasirox (EXJADE R ) – Doses

Safe and Efficient Chelation by Deferasirox In Thalassemia Major Patients with Low Liver and Cardiac Iron Concentrations

Comparison of the Predictive Value of MRD and PVA Score in Pediatric ALL.

High Expression of CD40 on BCP-ALL Blasts Is an Independent Risk Factor Associated with Improved Survival and Enhanced Capacity To Upregulate the Death Receptor CD95.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only